Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LYRA Lyra Therapeutics

盘后交易 11-22 18:33:32 EST

0.1890

+0.0071

+3.90%

盘后0.1915

+0.0025+1.32%

18:19 EST

最高0.1977	最低0.1823	成交量188.32万
今开0.1869	昨收0.1819	日振幅8.47%
总市值1,237万	流通市值788.25万	总股本6,546万
成交额35.82万	换手率4.52%	流通股本4,171万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LYRA","market":"US","secType":"STK","nameCN":"Lyra Therapeutics","latestPrice":0.189,"timestamp":1732309200000,"preClose":0.1819,"halted":0,"volume":1883198,"hourTrading":{"tag":"盘后","latestPrice":0.1915,"preClose":0.189,"latestTime":"18:19 EST","volume":12886,"amount":2400.4691543,"timestamp":1732317548808},"delay":0,"floatShares":41706536,"shares":65457648,"eps":-1.523496,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.0071,"latestTime":"11-22 18:33:32 EST","open":0.1869,"high":0.1977,"low":0.1823,"amount":358185.40835077997,"amplitude":0.084662,"askPrice":0.1916,"askSize":3500,"bidPrice":0.1822,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.523496,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732323600000},"adr":0,"listingDate":1588305600000,"adjPreClose":0.1819,"preHourTrading":{"tag":"盘前","latestPrice":0.1868,"preClose":0.1819,"latestTime":"09:23 EST","volume":24428,"amount":4517.393824639999,"timestamp":1732285420434},"postHourTrading":{"tag":"盘后","latestPrice":0.1915,"preClose":0.189,"latestTime":"18:19 EST","volume":12886,"amount":2400.4691543,"timestamp":1732317548808},"volumeRatio":0.362066,"impliedVol":3.1901,"impliedVolPercentile":0.9921},"requestUrl":"/m/hq/s/LYRA","defaultTab":"news","newsList":[{"id":"2485262327","title":"Lyra Therapeutics, Inc.盘中异动 早盘股价大涨5.17%报0.191美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485262327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485262327?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:51","pubTimestamp":1732287118,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时51分，Lyra Therapeutics, Inc.股票出现波动，股价快速上涨5.17%。截至发稿，该股报0.191美元/股，成交量19.3079万股，换手率0.29%，振幅2.58%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222515898e442be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112222515898e442be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2485741199","title":"Lyra Therapeutics, Inc.盘中异动 早盘股价大涨6.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485741199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485741199?lang=zh_cn&edition=full","pubTime":"2024-11-22 00:21","pubTimestamp":1732206063,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日00时21分，Lyra Therapeutics, Inc.股票出现波动，股价大幅上涨6.01%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002103abd515de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122002103abd515de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LYRA","LENZ"],"gpt_icon":0},{"id":"2484110819","title":"Lyra Therapeutics, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110819?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:38","pubTimestamp":1732113530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时38分，Lyra Therapeutics, Inc.股票出现异动，股价大幅跳水5.21%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223850abd235f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223850abd235f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2484924372","title":"Lyra Therapeutics, Inc.盘中异动 早盘大幅上涨5.36%报0.177美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484924372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484924372?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:02","pubTimestamp":1732032133,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时02分，Lyra Therapeutics, Inc.股票出现异动，股价快速上涨5.36%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.71%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120000213971a77a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120000213971a77a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","LYRA"],"gpt_icon":0},{"id":"2483037731","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨8.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483037731","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483037731?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681087,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Lyra Therapeutics, Inc.股票出现波动，股价大幅拉升8.28%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312795be340d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522312795be340d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LYRA","LENZ"],"gpt_icon":0},{"id":"2483017864","title":"Lyra Therapeutics, Inc.2024财年第三财季实现净利润-11.87百万美元，同比增加24.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483017864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483017864?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:00","pubTimestamp":1731542426,"startTime":"0","endTime":"0","summary":"11月14日，Lyra Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-11.87百万美元，同比增加24.15%；其中营业收入为195000.00美元，同比减少64.15%，每股基本收益为-0.18美元。从资产负债表来看，Lyra Therapeutics, Inc.总负债58.14百万美元，其中短期债务4.00百万美元，资产负债比为1.36，流动比率为3.65。机构评级：截至2024年11月14日，当前有1家机构对Lyra Therapeutics, Inc.目标价做出预测，其中目标均价为0.50美元，其中最低目标价为0.50美元，最高目标价为0.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080032a235587d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080032a235587d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","LENZ"],"gpt_icon":0},{"id":"2483052838","title":"Lyra Therapeutics Inc  预计每股亏损 19 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483052838","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483052838?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:51","pubTimestamp":1731513109,"startTime":"0","endTime":"0","summary":"Lyra Therapeutics Inc  预计每股亏损 19 美分 - 财报前瞻Lyra Therapeutics Inc LYRA.OQ LYRA.O在公布截至2024年12月31日的财报时，预计季度收入将有所增长。LSEG 的分析师平均预计 Lyra Therapeutics Inc 每股亏损 19 美分。华尔街对 Lyra Therapeutics Inc 的 12 个月目标价中位数为 1.25 美元，高于其最新收盘价 0.28 美元。11月13日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4S3MK1QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYRA"],"gpt_icon":0},{"id":"2483881295","title":"Lyra Therapeutics, Inc.盘中异动 快速下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483881295","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483881295?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:35","pubTimestamp":1731508556,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时35分，Lyra Therapeutics, Inc.股票出现波动，股价快速下挫5.09%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223556971a6495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223556971a6495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","LYRA","BK4139"],"gpt_icon":0},{"id":"2480856032","title":"Lyra Therapeutics, Inc.盘中异动 下午盘急速下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480856032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480856032?lang=zh_cn&edition=full","pubTime":"2024-11-02 02:56","pubTimestamp":1730487418,"startTime":"0","endTime":"0","summary":"北京时间2024年11月02日02时56分，Lyra Therapeutics, Inc.股票出现波动，股价快速跳水5.42%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102025658971a3ece&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241102025658971a3ece&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LYRA","BK4139","LENZ"],"gpt_icon":0},{"id":"2480884412","title":"Lyra Therapeutics Inc    预计每股亏损 23 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884412","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884412?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:14","pubTimestamp":1730470487,"startTime":"0","endTime":"0","summary":"   * Lyra Therapeutics Inc    预计将在11月5日公布截至2024年9月30日的业绩报告时显示季度收入下降(预计)    * 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于马萨诸塞州沃特敦的公司的营收预计将从一年前的54.4万美元下降41.2%至32万美元。* LSEG 分析师对 Lyra Therapeutics Inc 的平均预期是每股亏损 23 美分。* 华尔街对 Lyra Therapeutics Inc 的 12 个月目标价中位数为 1.25 美元，高于上一次 0.27 美元的收盘价。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYRA","LENZ"],"gpt_icon":0},{"id":"2479034920","title":"Lyra Therapeutics, Inc.盘中异动 急速上涨5.06%报0.286美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479034920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479034920?lang=zh_cn&edition=full","pubTime":"2024-10-31 22:42","pubTimestamp":1730385737,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日22时42分，Lyra Therapeutics, Inc.股票出现异动，股价急速上涨5.06%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.62%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224217971a3949&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031224217971a3949&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LYRA","BK4007","LENZ"],"gpt_icon":0},{"id":"2479132256","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479132256","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479132256?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:44","pubTimestamp":1730231077,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时44分，Lyra Therapeutics, Inc.股票出现波动，股价大幅拉升5.45%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030034437971a300f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030034437971a300f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2478487343","title":"Lyra Therapeutics, Inc.盘中异动 急速拉升5.88%报0.265美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478487343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478487343?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:35","pubTimestamp":1730126129,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时35分，Lyra Therapeutics, Inc.股票出现波动，股价大幅上涨5.88%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223530ab7be86e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028223530ab7be86e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","LYRA"],"gpt_icon":0},{"id":"2478930781","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.57%报0.267美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478930781","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478930781?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:37","pubTimestamp":1729870639,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时37分，Lyra Therapeutics, Inc.股票出现波动，股价快速上涨5.57%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233719971a25dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025233719971a25dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","LYRA"],"gpt_icon":0},{"id":"2477655952","title":"Lyra Therapeutics, Inc.盘中异动 急速上涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477655952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477655952?lang=zh_cn&edition=full","pubTime":"2024-10-24 00:49","pubTimestamp":1729702183,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日00时49分，Lyra Therapeutics, Inc.股票出现异动，股价快速上涨5.28%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.06%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024004943971a1db0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024004943971a1db0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LYRA","LENZ"],"gpt_icon":0},{"id":"2477330268","title":"Lyra Therapeutics, Inc.盘中异动 早盘快速上涨5.12%报0.257美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477330268","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477330268?lang=zh_cn&edition=full","pubTime":"2024-10-22 21:30","pubTimestamp":1729603849,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日21时30分，Lyra Therapeutics, Inc.股票出现波动，股价急速拉升5.12%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Tc Biopharm  Plc涨幅较大，Genprex, Inc.、Tc Biopharm  Plc、Ensysce Biosciences, Inc.较为活跃，换手率分别为1723.19%、1121.48%、1026.45%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为26.50%、17.88%、9.28%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221304998e3dc27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102221304998e3dc27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LYRA","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2476923572","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476923572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476923572?lang=zh_cn&edition=full","pubTime":"2024-10-19 02:42","pubTimestamp":1729276970,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日02时42分，Lyra Therapeutics, Inc.股票出现异动，股价大幅拉升5.88%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019024250a1e1c763&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019024250a1e1c763&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LYRA","BK4139","LENZ"],"gpt_icon":0},{"id":"2475391449","title":"Lyra Therapeutics, Inc.盘中异动 早盘大幅上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475391449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475391449?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:09","pubTimestamp":1729091363,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时09分，Lyra Therapeutics, Inc.股票出现波动，股价快速拉升5.08%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016230923ab6a91ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016230923ab6a91ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LYRA","BK4007"],"gpt_icon":0},{"id":"2474601684","title":"Lyra Therapeutics, Inc.盘中异动 股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474601684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474601684?lang=zh_cn&edition=full","pubTime":"2024-10-11 23:15","pubTimestamp":1728659720,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日23时15分，Lyra Therapeutics, Inc.股票出现异动，股价大幅上涨5.21%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112315209719fb48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410112315209719fb48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LYRA","BK4139","LENZ"],"gpt_icon":0},{"id":"2473647590","title":"Lyra Therapeutics, Inc.盘中异动 股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473647590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473647590?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:00","pubTimestamp":1728396041,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日22时00分，Lyra Therapeutics, Inc.股票出现波动，股价大幅下挫5.44%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822004298e3b2f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100822004298e3b2f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LYRA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lyratherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0106},{"period":"1month","weight":-0.2782},{"period":"3month","weight":-0.4244},{"period":"6month","weight":-0.4412},{"period":"1year","weight":-0.9409},{"period":"ytd","weight":-0.9653}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lyra Therapeutics, Inc. 成立于2005年11月21日，是特拉华州的一家公司。LyraTherapeutics，Inc.是一家临床阶段的治疗公司，致力于针对耳部患者的局部治疗的新型集成药物和递送解决方案的开发和商业化 ，鼻和喉（“ ENT”）疾病。 该公司的专有技术平台XTreo旨在通过一次给药就可以持续地将药物直接准确，持续地直接输送到受影响的组织。 该公司的最初产品候选产品LYR-210和LYR-220是可生物吸收的聚合物基质，旨在通过简短，无创的办公室内程序进行给药，旨在为鼻窦通道提供长达六个月的连续药物治疗 用于治疗慢性鼻鼻窦炎（“ CRS”）。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.089692},{"month":2,"riseRate":0.75,"avgChangeRate":0.148346},{"month":3,"riseRate":0.25,"avgChangeRate":-0.09267},{"month":4,"riseRate":0.5,"avgChangeRate":0.074484},{"month":5,"riseRate":0.25,"avgChangeRate":-0.301422},{"month":6,"riseRate":0.6,"avgChangeRate":0.066367},{"month":7,"riseRate":0.6,"avgChangeRate":0.018356},{"month":8,"riseRate":0.4,"avgChangeRate":0.009117},{"month":9,"riseRate":0.4,"avgChangeRate":-0.015801},{"month":10,"riseRate":0.2,"avgChangeRate":-0.095495},{"month":11,"riseRate":0.4,"avgChangeRate":-0.109511},{"month":12,"riseRate":0.25,"avgChangeRate":0.043528}],"exchange":"NASDAQ","name":"Lyra Therapeutics","nameEN":"Lyra Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lyra Therapeutics(LYRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lyra Therapeutics,LYRA,Lyra Therapeutics股票,Lyra Therapeutics股票老虎,Lyra Therapeutics股票老虎国际,Lyra Therapeutics行情,Lyra Therapeutics股票行情,Lyra Therapeutics股价,Lyra Therapeutics股市,Lyra Therapeutics股票价格,Lyra Therapeutics股票交易,Lyra Therapeutics股票购买,Lyra Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lyra Therapeutics(LYRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lyra Therapeutics(LYRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}